Hycamtin Capsules
"Lung cancer facts
- Lung cancer is the number-one cause of cancer deaths in both men and women in the U.S. and worldwide.
- Cigarette smoking is the principal risk factor for development of lung cancer. "...
Read the entire article on MedicineNet »
© 1999-2013 MedicineNet, Inc All right reserved
Hycamtin Capsules
HYCAMTIN®
(topotecan) Capsules
WARNING
BONE MARROW SUPPRESSION
HYCAMTIN should be administered only to patients with baseline neutrophil counts of ≥ 1,500 cells/mm³ and a platelet count ≥ 100,000 cells/mm³. In order to assess the occurrence of bone marrow suppression, blood cell counts should be monitored.
DRUG DESCRIPTION
Topotecan hydrochloride is a semi-synthetic derivative of camptothecin and is an anti-tumor drug with topoisomerase I-inhibitory activity.
The chemical name for topotecan hydrochloride is (S)-10-[(dimethylamino)methyl]-4ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7] indolizino [1,2-b]quinoline-3,14-(4H,12H)-dione monohydrochloride. It has the molecular formula C23H23N3O5•HCl and a molecular weight of 457.9. It is soluble in water and melts with decomposition at 213° to 218°C
Topotecan hydrochloride has the following structural formula:
 |
HYCAMTIN capsules contain topotecan hydrochloride, the content of which is expressed as topotecan free base. The major excipients are hydrogenated vegetable oil, glyceryl monostearate, gelatin, and titanium dioxide. The capsules are imprinted with edible black ink. The 1 mg capsules also contain red iron oxide.
Last reviewed on RxList: 7/26/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Hycamtin Capsules Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.
Updated & New
